elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36786002-0FCFCEFF-FE06-4D0F-A70F-CCF5DF0C9B8C
Q36786002-0FCFCEFF-FE06-4D0F-A70F-CCF5DF0C9B8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36786002-0FCFCEFF-FE06-4D0F-A70F-CCF5DF0C9B8C
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
P2860
Q36786002-0FCFCEFF-FE06-4D0F-A70F-CCF5DF0C9B8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36786002-0FCFCEFF-FE06-4D0F-A70F-CCF5DF0C9B8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a8433f6142bdc4c8937087d63913b8b1e023688d
P2860
Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.